How SPAIRE compares with other hip replacement approaches

Different hip replacement approaches are best compared by (1) the soft-tissue route used to reach the hip joint, (2) what that means for early recovery and stability, and (3) how mature the outcomes evidence is for that particular technique. To avoid a “numbers parade”, this section focuses mainly on the practical anatomical differences and uses the research only where it changes the decision picture.

Hip replacement and hip arthroplasty both describe replacing damaged hip joint surfaces with artificial components (a prosthesis) to relieve pain and restore function. Most planned operations for arthritis are total hip replacement (both ball and socket), while fracture care may involve hemiarthroplasty (replacing the femoral head only), depending on the pattern of injury and the patient’s needs.

Across posterior, direct anterior (DAA) and lateral approaches, surgeons are aiming for the same ball-and-socket hip joint, and the implant components are essentially the same; the key difference is which muscles and tendons are moved aside, divided, or left intact.

SPAIRE hip replacement sits within the posterior family but modifies the traditional posterolateral method to spare key stabilisers at the back of the hip. In published technical descriptions, SPAIRE preserves key short external rotators (including piriformis and obturator internus/conjoint tendon) while dividing and repairing obturator externus and the posterior capsule, aiming to keep more of the hip’s native posterior restraints intact while still using a versatile posterior exposure for the joint replacement work.

Compared with SPAIRE, the direct anterior approach reaches the hip from the front, typically working between muscles rather than detaching them, with the scar positioned differently on the thigh. In a meta-analysis of 24 randomised trials (2,010 total hip replacements), DAA showed faster early functional recovery and a slightly shorter hospital stay, at the cost of longer operating time on average; longer-term outcomes and major complications were broadly similar across approaches in that dataset.

Lateral approaches use a side route to the hip and are commonly discussed in fracture pathways as an established alternative to posterior surgery. In the displaced-femoral-neck-fracture setting (where hemiarthroplasty is common), a 2025 systematic review comparing SPAIRE with more traditional lateral/anterior approaches reported that SPAIRE tended to show better early mobility and pain scores, while longer-term function and outcomes such as mortality were broadly similar across techniques. This is also where the main evidence base for SPAIRE currently sits, so elective total hip replacement decisions for arthritis often rely more heavily on surgeon-specific experience and careful risk assessment than on large head-to-head total-hip datasets.

Who is likely to benefit from SPAIRE hip replacement

Suitability for a SPAIRE hip replacement is usually less about “posterior versus anterior” labels and more about what needs to be achieved in the first 6–12 weeks after surgery: stable movement in and out of bed, safe walking, and predictable soft-tissue recovery. Discussion of suitability also stands apart from questions about where surgery is done; the central issue is whether a muscle-sparing posterior approach is a good match for the person’s risks, anatomy and the operating surgeon’s most reproducible technique.

The published SPAIRE evidence base is currently weighted towards older, fracture-related surgery rather than planned total hip replacement for osteoarthritis. A 2025 systematic review totalling 1,385 hemiarthroplasties found SPAIRE tended to show early advantages in mobility and pain versus more traditional lateral/anterior fracture approaches, while longer-term function and outcomes such as mortality were broadly similar. These findings support the idea that SPAIRE can work well for early mobilisation in fracture pathways, but they do not yet provide large, elective total-hip datasets across varied implants and centres.

Certain clinical scenarios are often discussed in terms of stability and early independence. A published case report describes a 79-year-old woman with a transcervical femoral neck fracture treated with SPAIRE bipolar hemiarthroplasty and excellent function at 3 months, including a rationale for preserving posterior stabilisers in patients with neurological comorbidity.

In elective hip arthroplasty for osteoarthritis or avascular necrosis, SPAIRE is used in some surgeon practices across a range of body shapes and hip anatomies. The limitation is that these statements are often expert-practice descriptions rather than large comparative datasets in elective total hip replacement.

There are also situations where other choices may be preferred, even for someone concerned about instability. Approach selection is only one lever: in high-BMI patients, one comparative study found dual-mobility or constrained liners were more effective at preventing dislocation than attempting to reduce BMI via bariatric surgery, underlining how implant choice can matter as much as the surgical route.

• Patients commonly discussed as potential “good-fit” candidates for SPAIRE include fracture patients where early transfers and confident mobilisation matter, and selected higher-risk groups where stability is a priority.
• In elective arthritis surgery, SPAIRE may be considered where a posterior route is advantageous, provided the surgeon is experienced with the tendon-sparing repair strategy described in published SPAIRE technical reports.
• In some cases, a different approach (direct anterior, lateral, or another posterior variant) or a different implant strategy (e.g., dual-mobility) may be the more relevant stability tool than changing the skin incision alone.

What recovery looks like by hip replacement approach

A hip replacement recovery rarely feels “done” at 2 weeks or even 6 weeks; the more realistic marker is where the hip is heading by around 12 months. Across well-performed total hip arthroplasty, the long-term aim is the same regardless of incision route: a stable hip joint that is comfortable enough to fade into day-to-day life, even if the first 6–12 weeks can feel quite different between approaches.

One of the clearest patterns from higher-quality comparative evidence is this: the direct anterior approach (DAA) often buys a modest early advantage, but it does not reliably change the one-year destination. In a meta-analysis of 24 randomised trials (2,010 total hip replacements), DAA took longer in theatre (about 17 minutes on average) yet was linked to a slightly shorter hospital stay (about a third of a day) and better early Harris Hip Scores at roughly 6–12 weeks than posterior or lateral approaches; longer-term functional differences and major complication rates were not consistently different.

Modified posterior techniques aim to narrow the “anterior recovers faster” story by preserving or repairing the key stabilisers at the back of the joint. SPAIRE hip replacement sits in this category: in published descriptions it preserves piriformis and the obturator internus/conjoint tendon and repairs obturator externus with the posterior capsule.

Real-world SPAIRE recovery data are currently dominated by fracture and hemiarthroplasty cohorts, which matters when interpreting “how fast” in elective arthritis surgery. In a 2025 systematic review pooling 1,385 hemiarthroplasties, SPAIRE tended to improve early mobility and pain compared with more conventional lateral/anterior fracture approaches, while longer-term function and outcomes (including mortality) were broadly similar. Individual published case reports also describe good early function after SPAIRE hemiarthroplasty in older fracture patients.

Day-to-day, approach differences are often felt as where the early soreness sits rather than a completely different rehab pathway. Practical milestones (out of bed, walking with sticks, stairs) often overlap between approaches, while the extent of post-operative movement precautions (if any) varies by surgeon and by how much soft tissue was divided and then repaired.

Because the biggest gains are often in gait quality over the first few months (rather than simply “being able to walk”), objective measures can help keep recovery grounded in function rather than guesswork. The approach can influence early tissue irritation, but the one-year result is commonly shaped just as much by consistent physiotherapy, pain control, sleep, and avoiding complications as by whether the scar is on the front, side, or back of the hip.

How surgical approach affects hip joint dislocation risk

Dislocation after hip arthroplasty means the prosthetic ball comes out of the socket. It is an important complication because it can lead to urgent hospital treatment (often requiring reduction) and, in some cases, further surgery to restore stability.

A practical way to think about stability risk

In most modern pathways, dislocation risk is best understood as a layered issue rather than something determined by skin incision alone: (1) patient biomechanics, (2) surgical approach plus soft-tissue repair, and (3) implant positioning/biomechanics and, when needed, implant design.

1) Patient biomechanics and alignment

Even when a single approach is used consistently, patient-specific biomechanics can matter. In a cohort of 6,166 anterior-approach total hip arthroplasties, patients who dislocated had a high prevalence of adverse spinopelvic parameters and differences in implant version, hip length and femoral offset compared with non-dislocators, highlighting how stability can be driven by spinopelvic mechanics and component positioning.

2) Approach and soft-tissue strategy (what happens to the stabilisers)

Approach choice matters most when it changes the integrity of the tissues that resist posterior translation. In elderly patients undergoing total hip arthroplasty for femoral neck fractures, a meta-analysis of 15 studies found a significantly lower dislocation rate with the direct anterior approach than with the posterolateral approach.

Where SPAIRE hip replacement fits

SPAIRE hip replacement is a muscle-sparing posterolateral approach designed specifically to keep key posterior stabilisers functioning. Published descriptions describe preserving piriformis and the obturator internus/conjoint tendon while dividing and repairing obturator externus and the posterior capsule, with the aim of maintaining stabilising structures to decrease dislocation risk and support early recovery.

Comparative SPAIRE outcome evidence is currently strongest in fracture/hemiarthroplasty populations. A 2025 systematic review of 1,385 hemiarthroplasties reported better early mobility/pain with SPAIRE than more traditional approaches but broadly similar longer-term outcomes. In addition, a randomised trial comparing SPAIRE with the direct anterior approach in femoral neck fracture hemiarthroplasty reported similar periprosthetic bone mineral density changes over 12 months, suggesting periprosthetic fracture risk is unlikely to differ meaningfully between those approaches (at least as reflected by BMD change).

3) Biomechanics and implant choices (often decisive in higher-risk hips)

Beyond approach and repair, implant strategy can be an important stability lever in selected cases. In high-BMI patients, one comparative study reported that using dual-mobility or constrained liners was more effective at preventing dislocation than attempting to reduce BMI via preoperative bariatric surgery.

How approach and implants influence revision and cost

Revision hip arthroplasty is the outcome everyone is trying to avoid, because it is rarely a simple “swap” of parts. In general, revision total hip replacement is typically longer and more complex than a primary hip replacement because the surgeon may have to deal with altered bone stock, existing implants, and scarred or weakened soft tissue.

A useful framing question is: “Will the choice of hip replacement approach now make a big difference to whether revision is needed later?” When the primary operation is well executed, long-term revision risk does not appear to separate cleanly by “anterior versus posterior” branding alone. Randomised-trial meta-analysis data show the direct anterior approach tends to improve early recovery metrics without consistent differences in major complications compared with posterior or lateral approaches.

Even if approach branding does not fully predict revision risk, avoiding instability and other complications still matters because those events can drive unplanned readmissions and, in some cases, re-operation. Implant strategy can be part of that risk-management plan in selected patients: in high-BMI patients, one comparative study reported that dual-mobility or constrained liners were more effective at preventing dislocation than attempting to reduce BMI with preoperative bariatric surgery.

For patients who do need revision, the approach into the hip is typically selected pragmatically based on the reason for failure, the patient’s anatomy and biomechanics, and the surgeon’s ability to achieve stable component positioning and soft-tissue management.

Hip resurfacing or total hip replacement for younger adults

For some adults in their 30s, 40s or 50s, the choice is not only which total hip replacement approach (anterior, lateral, standard posterior or a muscle-sparing posterior approach such as SPAIRE hip replacement) but whether a hip resurfacing arthroplasty is even on the table. To keep SPAIRE “in context”, resurfacing sits here as a niche branch of hip arthroplasty decision-making, not a wholesale change in direction.

Hip resurfacing arthroplasty (HRA) preserves the patient’s femoral head and neck and places a cap over the femoral head, while resurfacing the acetabulum (socket). In a standard total hip replacement (THR/THA), the femoral head is removed and a stem is inserted into the femur, with a new head articulating in an acetabular cup. Modern resurfacing has most commonly been metal-on-metal, which is central to both its potential benefits and its specific risks.

Longer-term resurfacing data are encouraging in some groups but also explain why indications have narrowed. In the first 144 Birmingham Hip Resurfacing (BHR) procedures performed in 1997–1998, 25-year survival was 83.5% overall, with 89.5% survival in men versus 66.9% in women; additional late failures between 10 and 25 years were largely attributed to adverse reactions to metal debris, femoral neck fractures and aseptic loosening, and median chromium/cobalt levels were elevated at final follow-up.

A practical comparison (resurfacing vs total hip replacement) often looks like this:

• Bone preservation: HRA preserves more femoral bone; THA removes the head and uses a stem. (This can matter if future revision surgery is needed.)
• Bearing surface: HRA has typically been metal-on-metal; THA offers multiple bearing options. Metal ions and local soft-tissue reactions are key reasons resurfacing is now more selective.
• Best-fit patient profile (broadly): HRA tends to perform best in carefully selected groups, often younger and active patients with good bone quality; outcomes in women and smaller anatomy have been less favourable in several datasets. THA remains the standard for a much wider range of patients.

In consultant discussions, the decision usually comes down to three specifics on a given hip joint: (1) whether resurfacing is appropriate given bone quality and anatomy, (2) whether the bearing-related trade-offs (including metal-on-metal monitoring) are acceptable, and (3) if proceeding with THA, which approach best balances stability, recovery priorities and surgical access.

Hip Replacement Lincolnshire is part of the MSK Doctors group and accepts patients without referral; assessments can be booked at hipreplacementlincolnshire.co.uk.

1. [1] Rethinking hip surgery: A systematic review of sparing piriformis and internus, repairing externus (SPAIRE) vs. traditional hemiarthroplasty approaches. (2025). https://doi.org/10.7759/cureus.89115 https://doi.org/10.7759/cureus.89115